An adolescent with marked hyperimmunoglobulinemia E showing minimal change nephrotic syndrome and a STAT3 gene mutation

Clinical Nephrology

Volumn 75, Issue 4, 2011, Pages 369-373

  Miyazaki, K ^a   Miyazawa, T ^a   Sugimoto, K ^a   Fujita, S ^a   Yanagida, H ^a   Okada, M ^a   Takemura, T ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

IgE; Nephrotic syndrome; STAT3 gene mutation

Indexed keywords

ALANINE; CORTICOSTEROID; CYCLOSPORIN A; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 21; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; MIZORIBINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STAT3 PROTEIN; VALINE;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CASE REPORT; CHRONIC DISEASE; CORTICOSTEROID THERAPY; DRUG EFFECT; ECZEMA; EXON; GENE LOCATION; GENE MUTATION; HETEROZYGOSITY; HUMAN; HYPER IGE SYNDROME; IMMUNOGLOBULIN BLOOD LEVEL; IMPETIGO; MALE; MINIMAL CHANGE NEPHROTIC SYNDROME; NEPHROTIC SYNDROME; OTITIS MEDIA; PROTEINURIA; RECURRENT DISEASE; SCAR FORMATION; TH1 CELL; TH2 CELL; ADOLESCENT; GENETICS; LIPOID NEPHROSIS; MUTATION;

ADOLESCENT; HUMANS; JOB'S SYNDROME; MALE; MUTATION; NEPHROSIS, LIPOID; STAT3 TRANSCRIPTION FACTOR;

EID: 79961094854     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CN106548     Document Type: Article

References (18)

1. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M,Weiner HL, Kuchroo VK. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006; 441: 235-238.
2. Bong CN, Huang SC,Wang CL, Liu PM, Chen HH, Yang KD. Cyclosporin A therapy in a case with hyperimmunoglobulin E and nephrotic syndrome. J Microbiol Immunol Infect. 2005; 38: 60-64.
3. Etzioni A, Shehadeh N, Brecher A, Yorman S, Pollack S. Cyclosporin A in hyperimmunoglobulin E syndrome. Ann Allergy Asthma Immunol. 1997; 78: 413-414.
4. Grimbacher B, Holland SM, Puck JM. Hyper-IgE syndromes. Immunol Rev. 2005; 203: 244-250.
5. Holland SM, DeLeo FR, Elloumi HZ, Hsu AP, Uzel G, Brodsky N, Freeman AF, Demidowich A, Davis J, Turner ML, Anderson VL, Darnell DN, Welch PA, Kuhns DB, Frucht DM, Malech HL, Gallin JI, Kobayashi SD, Whitney AR, Voyich JM, Musser JM, Woellner C, Schäffer AA, Puck JM, Grimbacher B. STAT3 mutations in the hyper-IgE syndrome. N Engl J Med. 2007; 357: 1608-1619.
6. Kamimura D, Ishihara K, Hirano T. IL-6 signal transduction and its physiological roles: the signal orchestration model. Rev Physiol Biochem Pharmacol. 2003; 149: 1-38.
7. Levy DE, Lee CK. What does Stat3 do? J Clin Invest. 2002; 109: 1143-1148.
8. Li R, Yang N, Zhang L, Huang Y, Zhang R,Wang F, Luo M, Liang Y, Yu X. Inhibition of Jak/STAT signaling ameliorates mice experimental nephrotic syndrome. Am J Nephrol. 2007; 27: 580-589.
9. Minegishi Y, Karasuyama H. Hyper IgE syndrome and Tyk2 deficiency. Current Opinion in Allergy Clinical Immunol. 2007; 7: 506-509.
10. Minegishi Y, Saito M, Tsuchiya S, Tsuge I, Takada H, Hara T, Kawamura N, Ariga T, Pasic S, Stojkovic O, Metin A, Karasuyama H. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature. 2007; 448: 1058-1062.
11. Minegishi Y, Karasuyama H. Genetic origins of hyper-IgE syndrome. Curr Allergy Asthma Rep. 2008; 8: 386-391.
12. North J, Kotecha S, Houtman P, Whaley K. Systemic lupus erythematosus complicating hyper IgE syndrome. Br J Rheumatol. 1997; 36: 297-298.
13. Sahali D, Pawlak A, Le Gouvello S, Lang P, ValanciutéA,RemyP, Loirat C, NiaudetP,Bensman A, Guellaen G. Transcriptional and post-transcriptional alterations of IkBα in active minimal-change nephrotic syndrome. J Am Soc Nephrol. 2001; 12: 1648-1658.
14. Schindler C, Darnell JE Jr. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu Rev Biochem. 1995; 64: 621-651.
15. Tanji C, Yorioka N, Kanahara K, Naito T, Oda H, Ishikawa K, Taguchi T. Hyperimmunogloblin E syndrome associated with nephrotic syndrome. Intern Med. 1999; 38: 491-494.
16. Tenbrock K, Schubert A, Stapenhorst L, Kemper MJ, Gellermann J, Timmermann K, Müller-Wiefel DE, Querfeld U, Hoppe B, Michalk D. Type I IgE receptor, interleukin 4 receptor and interleukin 13 polymorphisms in children with nephrotic syndrome. Clin Sci. 2002; 102: 507-512.
17. Wilson NJ, Boniface K, Chan JR, McKenzie BS, Blumenschein WM, Mattson JD, Basham B, Smith K, Chen T, Morel F, Lecron JC, Kastelein RA, Cua DJ, McClanahan TK, Bowman EP, de Waal Malefyt R. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol. 2007; 8: 950-957.
18. Van den Berg JG,Weening JJ. Role of immune system in the pathogenesis of idiopathic nephrotic syndrome. Clin Sci. 2004; 107: 125-136.